Moneycontrol
HomeNewscoronavirusActive COVID-19 cases mount; Mumbai shows signs of flattening curve 

Active COVID-19 cases mount; Mumbai shows signs of flattening curve 

 Many experts say the surge in cases may have already lost momentum.    

June 20, 2022 / 13:54 IST
Story continues below Advertisement

COVID-19 cases are rising consistently across India, but Mumbai, often held up as the bellwether for assessing the state of the pandemic,  is offering a glimmer of hope.

On Monday, June 20, India reported a total 12,781 COVID-19 cases; the number of active cases increased by 4,226 and reached 76, 700.

Story continues below Advertisement

Active cases are those that are yet to complete a 14 day-cycle and are currently in the "infectious” stage. Because a large number of people are also declared "recovered" from the disease daily, active cases are calculated by subtracting the number of recovered patients from the new ones. ​

Of the new cases, 4,004 were recorded in Maharashtra, followed by 3,376 in Kerala and 1,530 in Delhi.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show